Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Redd&Whyte Appoints New Director of Business Development

Published: Thursday, August 23, 2012
Last Updated: Wednesday, August 22, 2012
Bookmark and Share
Appointment of Rob Harkness as part of new growth strategy.

RobHarkness.gifRedd&Whyte has appointed Rob Harkness, PhD, to Director of Business Development in order to expand Redd&Whyte’s customer base across Europe and north America.

The appointment is one of a series of new hires, amid strategic restructuring within Redd&Whyte.

Rob Harkness brings specialist technical understanding of software and robotics, in addition to an impressive track record in business development.

He joins Redd&Whyte from Process Analysis & Automation, Ltd (PAA), where he worked for 13 years, initially as a software programmer and project manager, before progressing to leading Business Development in 2010.

His PhD (University of Surrey) focused on novel scheduling software for biochemical assays.

Rob made a significant contribution to PAA’s success in becoming a major provider of laboratory automated solutions, and will now lead Redd&Whyte’s global Business Development team.

“This is a crucial time for our company,” said Roger Poole, Managing Director at Redd&Whyte. “We have been making significant changes on a number of levels over the past few months, and Rob’s appointment forms an important part of our new business strategy.”

“It also demonstrates our continued commitment to developing enabling technology for our customers, through our approach of open innovation,” Roger said.

Roger continued, “Our products, including the award-winning Preddator microplate dispenser, are all developed through close collaboration with our customers, to help solve their liquid handling challenges and overcome perceived barriers to research.”

Redd&Whyte is involved in developing a range of novel robotic instruments with the fluid handling capabilities that laboratory scientists need to actually achieve their research visions.

The company’s specialist areas include nano dispensing, high throughput screening and point of care (PoC) testing.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
Developing Novel Ear Infection Treatments
Research team engineers antibiotic gel for treating middle ear infections.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Stem Cell ‘Heart Patch’ Almost Perfected
Scientists aiming to perfect and test 3D "heart patches" in animal model, last hurdle before human patients.
Fighting Cancer with Sticky Nanoparticles
Treatment that uses bioadhesive nanoparticles drug carriers proved more effective than conventional treatments for certain cancers.
Smart Material Hunts Cancers
Team has created smart material that locates and images cancer or tumour sites in tissue.
Targeting Fat to Treat Cancer
Researchers develop novel cancer treatment that halts fat synthesis in cells, stunting tumors.
Reprogramming Lymph Nodes to Fight MS
Bioengineers work to reprogram lymph node function to fight multiple sclerosis.
Arms Race with a Superbug
Scientists have discovered that increased risk of superbug infection can be directly casued by immune system response to invading bacteria.
High-Capacity Nanoparticles
New type of nanoparticle can now have three or more drugs packaged within it, allowing for customised cancer therapy.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!